ELMS STEVE purchased 0.7% of their position (14K shares) of ADMA BIOLOGICS, INC. on the open market
Open‑market purchase worth $217.4K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/9/2026ACC: 0001140361-26-008363
+14K
Net shares
Net buyer
$217.4K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
14K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+7K
Price / share
$15.67
Trade value
$109.69K
% of position
0.3%
3/5/2026
2.03M→2.04M
Common Stock
Indirect
Shares
+7K
Price / share
$15.39
Trade value
$107.73K
% of position
0.3%
3/6/2026
2.04M→2.05M
Total
Net shares
+14K
Net value
$217.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/5/2026 | P · Purchase | +7K | $15.67 | $109.69K | 0.3% | 2.03M | 2.04M |
| Common Stock Indirect | 3/6/2026 | P · Purchase | +7K | $15.39 | $107.73K | 0.3% | 2.04M | 2.05M |
| Total | +14K | $217.42K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned98.02K
Total
98.02K direct98.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 98.02K | Direct |
| Total | 98.02K | 98.02K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported